Compass Therapeutics • CMPX
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Thomas J. Schuetz, M.D.,PhD$203.6M
Market Cap • 24/04/20242018
(há 6 anos)
2020
(4 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts26
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CMPXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.